About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Polypharmacy in Clozapine-resistant Schizophrenia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00918021

Polypharmacy in Clozapine-resistant Schizophrenia

The aim of this randomized, double-blind study is to verify the hypothesis that clozapine monotherapy is as efficient as a combination of clozapine and olanzapine therapy in treatment-resistant schizo...

Lead sponsor: Niuvanniemi Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Niuvanniemi Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age ≥18 years, (adult), legally competent
•the patient is able to understand the purpose of the study and is eligible to sign the written informed consent form.
•insufficient response to the valid clozapine-olanzapine -polypharmacy
•psychotropic medication has been constant (unchangeable) during the past 2 months

Exclusion Criteria

•Pregnancy

Related studies

RECRUITINGPhase 3

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

NCT07565428 · Negative Symptoms of Schizophrenia

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more

Deep Brain Stimulation for Psychosis

NCT06257056 · Treatment-Refractory Schizophrenia

RECRUITINGPhase 2

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

NCT07288333 · Schizophrenia

RECRUITINGPhase 3

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

NCT07105098 · Schizophrenia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 19, 2010Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment30

Start dateJun 2009

Last updatedNov 19, 2010

Condition

Schizophrenia Schizoaffective Disorder

Locations shown

Niuvanniemi Hospital

Kuopio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2010Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions